HKSE - Delayed Quote HKD

GLOBAL BIO-CHEM (0809.HK)

Compare
0.093
+0.001
+(1.09%)
At close: January 24 at 3:03:31 PM GMT+8
Currency in HKD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,373,938.000
1,373,938.000
12,711.000
746,551.000
848,867.000
Cost of Revenue
1,330,301.000
1,330,301.000
5,381.000
698,200.000
774,767.000
Gross Profit
43,637.000
43,637.000
7,330.000
48,351.000
74,100.000
Operating Expense
370,153.000
370,153.000
267,361.000
430,866.000
416,855.000
Operating Income
-326,516.000
-326,516.000
-260,031.000
-382,515.000
-342,755.000
Net Non Operating Interest Income Expense
-750,348.000
-750,348.000
-685,156.000
-790,314.000
-724,423.000
Pretax Income
3,701,045.000
3,701,045.000
-1,424,946.000
-409,469.000
-2,410,926.000
Tax Provision
-42,082.000
-42,082.000
-46,788.000
25,920.000
22,340.000
Net Income Common Stockholders
4,224,593.000
4,224,593.000
-1,443,068.000
-400,801.000
-2,429,949.000
Average Dilution Earnings
-131,547.000
--
--
--
--
Diluted NI Available to Com Stockholders
4,224,593.000
4,224,593.000
-1,443,068.000
-400,801.000
-2,429,949.000
Basic EPS
0.47
0.47
-0.16
-0.04
-0.29
Diluted EPS
0.29
0.29
-0.16
-0.04
-0.29
Basic Average Shares
8,907,405.717
8,907,405.717
8,907,405.717
8,907,405.717
8,507,940.377
Diluted Average Shares
14,080,165.550
14,080,165.550
8,907,405.717
8,907,405.717
8,507,940.377
Total Expenses
1,700,454.000
1,700,454.000
272,742.000
1,129,066.000
1,191,622.000
Net Income from Continuing & Discontinued Operation
4,224,593.000
4,224,593.000
-1,443,068.000
-400,801.000
-2,429,949.000
Normalized Income
-13,014.750
-13,014.750
-1,303,867.104
-1,425,016.750
-1,890,037.500
Interest Income
3.000
3.000
22.000
271.000
403.000
Interest Expense
750,351.000
750,351.000
685,178.000
790,585.000
724,826.000
Net Interest Income
-750,348.000
-750,348.000
-685,156.000
-790,314.000
-724,423.000
EBIT
4,451,396.000
4,451,396.000
-739,768.000
381,116.000
-1,686,100.000
EBITDA
4,756,567.000
4,756,567.000
-409,259.000
783,629.000
-1,229,172.000
Reconciled Cost of Revenue
1,330,301.000
1,330,301.000
5,381.000
698,200.000
774,767.000
Reconciled Depreciation
305,171.000
305,171.000
330,509.000
402,513.000
456,928.000
Net Income from Continuing Operation Net Minority Interest
3,743,127.000
3,743,127.000
-1,301,661.000
-400,801.000
-2,429,949.000
Total Unusual Items Excluding Goodwill
5,008,189.000
5,008,189.000
2,281.000
1,365,621.000
-719,882.000
Total Unusual Items
5,008,189.000
5,008,189.000
2,281.000
1,365,621.000
-719,882.000
Normalized EBITDA
-251,622.000
-251,622.000
-411,540.000
-581,992.000
-509,290.000
Tax Rate for Calcs
0.000
0.000
0.000
0.000
0.000
Tax Effect of Unusual Items
1,252,047.250
1,252,047.250
74.896
341,405.250
-179,970.500
12/31/2020 - 3/16/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade
Waiting for permission
Allow microphone access to enable voice search

Try again.